Kamala Harris (Photo: Bloomberg)
Democratic Vice Presidential nominee Kamala Harris on Saturday (local time) said that she would not trust Donald Trump alone on a coronavirus vaccine adding that it would have to be a "credible source" that talks about "the efficacy and the reliability of whatever he's talking about".
In an interview with CNN, Harris said that it was "going to be an issue for all of us" to get a vaccine that was approved and distributed before the presidential elections.
"I will say that I would not trust Donald Trump and it would have to be a credible source of information that talks about the efficacy and the reliability of whatever he's talking about. I would not take his word," CNN reported quoting Harris.
The California Senator further said that public health experts would be "suppressed, sidelined" with regard to getting the last word on the efficacy of the vaccine.
"If past is the prologue that they will not, they'll be muzzled, they'll be suppressed, they will be sidelined because he's looking at an election coming up in less than 60 days and he's grasping to get whatever he can to pretend he has been a leader on this issue when he is not."
As per the latest update, the US has a total of 6,232,889 COVID-19 cases and 188,252 deaths due to the coronavirus, according to Johns Hopkins University.
The Presidential elections are scheduled to be held on November 3.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.